--2024/Q4-- / 31.251M--
--2024/Q3-- / 620.000--
Aug 8, 20242024/Q25.000K / 620.000--
May 9, 20242024/Q15.000K / 0.000--
Mar 27, 20242023/Q437.000K / 2.140K--
US Stock MarketDetailed Quotes
ALT Altimmune
- 6.490
- +0.250+4.01%
Close Aug 16 16:00 ET
- 6.574
- +0.084+1.30%
Post 19:59 ET
461.25MMarket Cap-3981P/E (TTM)
6.590High6.130Low2.45MVolume6.200Open6.240Pre Close15.69MTurnover3.48%Turnover RatioLossP/E (Static)71.07MShares14.84052wk High3.02P/B457.88MFloat Cap2.09052wk Low--Dividend TTM70.55MShs Float978.000Historical High--Div YieldTTM7.37%Amplitude-1731.000Historical Low6.401Avg Price1Lot Size
Altimmune Key Stats
Altimmune Q2 2024 Earnings Date
Currency：USDAug 8, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 620.00 | 5.00K | +4.38K |
| Beat Est. | -89.67% | -16.67% | +706.45% |
| EPS | -0.34 | -0.35 | -<0.01 |
| Miss Est. | -7.81% | -9.37% | -1.48% |
Analyst Rating
Aug 14, 2024
Altimmune Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Altimmune Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
